What it sells
Simulation platform for autonomous surgery.
Business model breakdown
Buyer: who owns the budget?
UnverifiedR&D/engineering leaders at medical device companies developing procedural and robotic devices.
Trigger: what makes them buy now?
Devices becoming software-defined/autonomous; need faster, regulator-ready evidence than cadaveric testing allows.
Workflow: what inputs become what output?
Cloud simulation replaces much cadaver/physical testing, running development cycles overnight with traceable documentation for submissions.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-07-23 | — | $11.5M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.